Britannia Life Sciences Inc. BLAB.CN Stock
0.07 CAD
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Canada
Exchange
Canadian Sec
Market Cap
11.36M CAD
LOW - HIGH [24H]
0.07
-
0.07 CAD
VOLUME [24H]
0 CAD
{{ volume }}
P/E Ratio
7.00
Earnings per share
0.01 CAD
Britannia Life Sciences Inc. Price Chart
Britannia Life Sciences Inc. BLAB.CN Financial and Trading Overview
| Britannia Life Sciences Inc. stock price | 0.07 CAD |
| Previous Close | 0.13 CAD |
| Open | 0 CAD |
| Bid | 0.14 CAD x N/A |
| Ask | 0.14 CAD x N/A |
| Day's Range | 0 - 0 CAD |
| 52 Week Range | 0 - 0.15 CAD |
| Volume | 0 CAD |
| Avg. Volume | 100.86K CAD |
| Market Cap | 19.47M CAD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | Infinity |
| EPS (TTM) | 0.01 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BLAB.CN Valuation Measures
| Enterprise Value | 29.87M CAD |
| Trailing P/E | Infinity |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.9936857 |
| Price/Book (mrq) | 3.3333335 |
| Enterprise Value/Revenue | 4.593 |
| Enterprise Value/EBITDA | 140.915 |
Trading Information
Britannia Life Sciences Inc. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -11.11% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.15 CAD |
| 52 Week Low | 0 CAD |
| 50-Day Moving Average | 0.11 CAD |
| 200-Day Moving Average | 0.1 CAD |
BLAB.CN Share Statistics
| Avg. Volume (3 month) | 100.86K CAD |
| Avg. Daily Volume (10-Days) | 65.74K CAD |
| Shares Outstanding | 162.25M |
| Float | 91.68M |
| Short Ratio | 0.09 |
| % Held by Insiders | 37.62% |
| % Held by Institutions | 0.92% |
| Shares Short | 21.73K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.010% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | March 31, 2023 |
Profitability
| Profit Margin | -12.22% |
| Operating Margin (ttm) | 2.10% |
| Gross Margin | 69.91% |
| EBITDA Margin | 3.25% |
Management Effectiveness
| Return on Assets (ttm) | 0.38% |
| Return on Equity (ttm) | 1.37% |
Income Statement
| Revenue (ttm) | 6.5M CAD |
| Revenue Per Share (ttm) | 0.04 CAD |
| Quarterly Revenue Growth (yoy) | -0.40% |
| Gross Profit (ttm) | 5.27M CAD |
| EBITDA | 211.97K CAD |
| Net Income Avi to Common (ttm) | -795334 CAD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.44M CAD |
| Total Cash Per Share (mrq) | 0.02 CAD |
| Total Debt (mrq) | 8.26M CAD |
| Total Debt/Equity (mrq) | 86.62 CAD |
| Current Ratio (mrq) | 0.926 |
| Book Value Per Share (mrq) | 0.036 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.85M CAD |
| Levered Free Cash Flow (ttm) | 1.16M CAD |
Profile of Britannia Life Sciences Inc.
| Country | Canada |
| State | ON |
| City | Toronto |
| Address | 120 Adelaide Street West |
| ZIP | M5H 1T1 |
| Phone | N/A |
| Website | https://britannia.life |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Britannia Life Sciences Inc. provides product testing, safety assessment, and compliance services to the cosmetics, nutraceutical, and consumer packaged goods industries in the United Kingdom and internationally. The company is based in Toronto, Canada.
Q&A For Britannia Life Sciences Inc. Stock
What is a current BLAB.CN stock price?
Britannia Life Sciences Inc. BLAB.CN stock price today per share is 0.07 CAD.
How to purchase Britannia Life Sciences Inc. stock?
You can buy BLAB.CN shares on the Canadian Sec exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Britannia Life Sciences Inc.?
The stock symbol or ticker of Britannia Life Sciences Inc. is BLAB.CN.
Which industry does the Britannia Life Sciences Inc. company belong to?
The Britannia Life Sciences Inc. industry is Biotechnology.
How many shares does Britannia Life Sciences Inc. have in circulation?
The max supply of Britannia Life Sciences Inc. shares is 162.25M.
What is Britannia Life Sciences Inc. Price to Earnings Ratio (PE Ratio)?
Britannia Life Sciences Inc. PE Ratio is 7.00000000 now.
What was Britannia Life Sciences Inc. earnings per share over the trailing 12 months (TTM)?
Britannia Life Sciences Inc. EPS is 0.01 CAD over the trailing 12 months.
Which sector does the Britannia Life Sciences Inc. company belong to?
The Britannia Life Sciences Inc. sector is Healthcare.